Population
51 patients with hypertrophic cardiomyopathy (HCM)
Design
Cohort
Follow-up
mean 6.5 years (minimum 3 years)
Authors
Loading...
Progressive LV enlargement signals high CHF mortality risk in HCM; leaves open whether early intervention modifies outcomes in this subgroup.
A subgroup of patients with hypertrophic cardiomyopathy develops progressive left ventricular enlargement and systolic dysfunction resembling dilated cardiomyopathy, which carries a high risk of mortality from congestive heart failure.
Hina et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: